Charles Sternberg, Assistant Editor02.08.21
Josh Pang joined Orchid Orthopedic Solutions as chief commercial officer (CCO) on February 1, 2021.
Pang comes to Orchid from Conmed, where he held roles of increasing responsibility and influence. He most recently held the role of vice president of orthopedic sales, where he was responsible for managing the United States sales force for the Orthopedic business. He has a reputation for growing market share through relationship building and concentrated execution. Previous to Conmed, Pang held various roles at Smith and Nephew, Pfizer and J&J.
“One of the key enablers of Orchid’s business strategy is a focus on our customers. We know that having a strong relationship with our customers helps drive growth. To continue building on our foundation of customer relationships, I am pleased to announce the addition of Josh Pang to the Orchid Leadership Team,” said Nate Folkert, Orchid’s chief executive officer.
Pang comes to Orchid from Conmed, where he held roles of increasing responsibility and influence. He most recently held the role of vice president of orthopedic sales, where he was responsible for managing the United States sales force for the Orthopedic business. He has a reputation for growing market share through relationship building and concentrated execution. Previous to Conmed, Pang held various roles at Smith and Nephew, Pfizer and J&J.
“One of the key enablers of Orchid’s business strategy is a focus on our customers. We know that having a strong relationship with our customers helps drive growth. To continue building on our foundation of customer relationships, I am pleased to announce the addition of Josh Pang to the Orchid Leadership Team,” said Nate Folkert, Orchid’s chief executive officer.